Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521019 | 0.98 | ATM (0.77) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL10713334 | 0.96 | ATM (0.74) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6522727 | 0.93 | ATM (0.63) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6519385 | 0.92 | HCAR2 (0.66) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6515103 | 0.91 | HCAR2 (0.69) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL4985840 | 0.91 | HCAR2 (0.64) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6518223 | 0.89 | ATM (0.58) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6516016 | 0.88 | ATM (0.62) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6517421 | 0.88 | HCAR2 (0.61) | ATMHCAR2NPSR1MAPTRAB9A | |
| SCHEMBL6523192 | 0.87 | ATM (0.71) | ATMHCAR2NPSR1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | ATM 4559/4885HCAR2 3143/4885NPSR1 4153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.